Ensure Cardiac Resynchronization Therapy Study

Medtronic Cardiac Rhythm and Heart Failure0 sites430 target enrollmentMay 2004

ConditionsHeart Failure

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Heart Failure
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Enrollment: 430
Status: Completed
Last Updated: 18 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate the therapy approach for converting abnormally fast heartbeats into normal heartbeats. There are no experimental devices or procedures involved in this study.

Registry

clinicaltrials.gov

Start Date

May 2004

End Date

February 2006

Last Updated

18 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Medtronic Cardiac Rhythm and Heart Failure

Eligibility Criteria

Inclusion Criteria

•Patient is indicated for a Medtronic CRT-D system
•Patient is willing to sign Permission for Access to and Use of Health Information form
•Patient is willing and able to comply with follow-up visits through six months

Exclusion Criteria

•Patient has a life expectancy of less than 6 months
•Patient is participating in any concurrent study that could confound the results for either study